Free Biopharma Daily Stock Updates - 02/10/22
$XBI $94.36 | -2.98% Covid Updates $NVAX -4.1% Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of...
top of page
BPIQ Blog
Feb 10, 20221 min read
VKTX - Bull Thesis
BULL THESIS VKTX overall corporate summary Focus on novel therapeutics for metabolic and endocrine diseases, especially NASH As of...
Feb 9, 20222 min read
Free Biopharma Daily Stock Updates - 02/09/22
$XBI $97.26 | +4.65% Covid Updates $IGMS +9.4% IGM Biosciences Advances Novel Antibody IGM-6268 Into Clinical Trials for the Treatment...
Feb 9, 20223 min read
INO - Bull Thesis
(Updated 3/24/22 based on quarterly report) BULL THESIS INO Corporate and summary ~ $400M in cash (~2 years) Extensive clinical pipeline...
Feb 8, 20221 min read
Free Biopharma Daily Stock Updates - 02/08/22
$XBI $92.94 | -0.33% Covid Updates $NVAX -12.0% Novavax falls short of COVID-19 vaccine deliveries - Reuters. source $IMNM -4.3%...
Feb 7, 20221 min read
Free Biopharma Daily Stock Updates - 02/07/22
$XBI $93.25 | +2.8% Covid Updates $RDHL -5.5% RedHill Biopharma's Oral Opaganib Reduces Mortality by 70% Given on Top of Remdesivir and...
Feb 4, 20222 min read
PDSB - Bull Thesis
BULL THESIS PDSB overall corporate and summary Immuno-oncology company with novel cancer vaccine technology Initial efficacy results...
Feb 4, 20221 min read
Biopharma Pulse - 1/31-2/4 Week in Review
As February begins, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD...
Feb 4, 20221 min read
Free Biopharma Daily Stock Updates - 02/04/22
$XBI $90.79 | +1.5% Covid Updates $NVAX +1.0% - New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine. source...
Feb 3, 20221 min read
Free Biopharma Daily Stock Updates - 02/03/22
$XBI $89.44 | -2.62% Covid Updates $NVAX -1.1% Medicines and Healthcare Products Regulatory Agency Grants Conditional Marketing...
Feb 2, 20222 min read
Free Biopharma Daily Stock Updates - 02/02/22
$XBI $91.85 | -3.3% Covid Updates $AVIR -3.7% Atea Pharmaceuticals Announces Publication of Data Supporting Bemnifosbuvir’s (AT-527)...
Feb 1, 20221 min read
Biopharma Pulse - 1/1-1/31 Month in Review
Below we review moves from smid-cap biopharma companies during January 2022. See Table 1 for monthly moves for companies and categories...
Feb 1, 20222 min read
Free Biopharma Daily Stock Updates - 02/01/22
$XBI $94.94 | +1.62% Covid Updates $PFE +0.7% & $BNTX +4.4% Pfizer and BioNTech Initiate Rolling Submission for Emergency Use...
Jan 31, 20222 min read
Free Biopharma Daily Stock Updates - 01/31/22
$XBI $93.43 | +5.48% Covid Updates $MRNA +6.2% Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine Spikevax source $NVAX +13.0%...
Jan 28, 20221 min read
Biopharma Pulse - 1/24-1/28 Week in Review
As the last full week of January comes to a close, we review moves from smid-cap biopharma companies during this past week. See Table 1...
Jan 28, 20221 min read
Free Biopharma Daily Stock Updates - 01/28/22
$XBI $88.58 | +3.59% Covid Updates $SRNE +2.8% Sorrento Announces Its Oral SARS-CoV-2 Main Protease (Mpro) Inhibitor, STI-1558, Strongly...
Jan 27, 20221 min read
Free Biopharma Daily Stock Updates - 01/27/22
$XBI $85.51 | -4.55% Covid Updates $TFFP -8.5% TFF Pharmaceuticals Completes Enrollment in Phase 1 Study Evaluating Inhaled Formulation...
Jan 27, 20223 min read
FGEN - Bull Thesis
(Updated on 3/24/22 based on quarterly report) BULL THESIS FGEN overall corporate and executive summary FGEN has lots of cash and revenue...
Jan 27, 20222 min read
ITCI - Bull Thesis
(Updated 3/24/22 based on quarterly report) BULL THESIS ITCI overall corporate and executive summary ITCI currently has no debt ITCI has...
Jan 27, 20221 min read
CARA - Bull Thesis
(Updated on 8/31/22 based on quarterly report) BULL THESIS SUMMARY CARA overall corporate and summary IV Korsuva Recently approved...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page